Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novartis AG (CH:NOVN – Research Report), Carl Zeiss Meditec (GB:0DHC – Research Report) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD – Research Report) with bullish sentiments.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)

Jarden analyst Steven Wheen maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh yesterday and set a price target of A$31.33. The company’s shares closed last Wednesday at A$28.93, close to its 52-week high of A$30.08.

According to TipRanks.com, Wheen is a 4-star analyst with an average return of 11.0% and a 55.0% success rate. Wheen covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals Ltd., Ramsay Health Care, and Cochlear Limited.

Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$33.20.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.